Diabetes Mellitus
Summary
- Elevated perioperative blood glucose >10mmol/L is associated with poor outcomes
- Poor blood glucose control needs screening for microvascular and macrovascular disease including cardiovascular and renal comorbidities
- Extremely high blood glucose levels can cause ketoacidosis or hyperosmolar hyperglycemic state
- All patients with history of DM must have HbA1c measured within 3 months
- Any patient presenting for elective surgery with HbA1c > 8% requires OPD referral for diabetes management and delay of surgery until BG management improves (at least 2 weeks)
Background
- Diabetes Mellitus (DM) is an endocrine, metabolic disorder marked by high levels of blood glucose. The incidence of DM in Kenya is 3.3% and increasing. Three classifications of diabetics exist:
Type 1 Diabetes
- an immune-mediated destruction of pancreatic beta cells causes a total reduction in endogenous insulin
Type II Diabetes
- patients experience increasing insulin resistance for the level of endogenous insulin, sometimes in combination with failure of pancreatic beta cells
Gestational Diabetes
- hyperglycemia occurs in the second or third trimester of pregnancy
Risk Factors
- Obesity: BMI>30, waist circumference >94cm (men); >90cm (Asian men); >80cm (all women)
- Hypertension or cardiovascular disease
- Frequent infections, particularly skin infections
- History of gestational diabetes (every 2 years)
- FH of diabetes - parent, sibling (every 2 years)
- If taking drugs that can cause high blood glucose (corticosteroids >1m, ARVs, antipsychotics)
- TB
Diagnosis
- If symptomatic: One abnormal result – HbA1c >6.5 OR Fasting Sugar >7
- If asymptomatic: Two abnormal results at two different times - HbA1c >6.5 OR Fasting sugar >7
Anaesthesia Evaluation
- In patients with DM presenting for anaesthesia evaluation, ensure that an HbA1c is available within the last 3 months
- For HbA1c < 8%, continue current management and proceed with evaluation
- For HbA1c > 8%, refer to OPD for medication adjustment and postpone surgery until patient demonstrates improved glycemic control
- Screen patient history and exam for cardiovascular and renal disease. Further labs and studies dictated by patient history, exam, and surgical severity with a lower threshold to obtain ECG or echo.
Medication Management
Drug Class | Medication | Day of Surgery | Notes |
---|---|---|---|
Sulfonylureas | Glipizide/glyburide | Do not take | Risk of hypoglycemia when NPO |
Biguanides | Metformin | Do not take | Risk of metabolic acidosis |
Insulin | Glargine ==long-acting== | 80% of usual dose | Risk of hypoglycemia when NPO |
Insulin | Mixtard ==combination short- and long-acting== | 50% of usual dose | Risk of hypoglycemia when NPO |